Print

BioTime (BTX) CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2012  
9/19/2012 9:54:39 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) announced that Chief Executive Officer Michael D. West, Ph.D. will present at the Stem Cells USA & Regenerative Medicine Congress 2012 in Cambridge, MA on Thursday, September 20, 2012. Dr. West will speak on “Second Generation hES Cell-Based Therapies: Achieving Purity and Scalability in the Midst of Diversity” in the session Developments in Novel Therapeutics. The presentation will be made available on BioTime's website at www.biotimeinc.com.
//-->